← Back to guidelines
Anesthesiology3 papers

Ketamine use disorder

Last edited:

Clinical Presentation

Patients receiving oral ketamine showed a decrease in median MMEs from the first to the last day of therapy, indicating potential efficacy in pain management [PMID:39264732].

Management

In a retrospective review of hospitalized patients, the median starting dose of oral ketamine was 1 mg/kg/day, with a median maximum dose of 1.6 mg/kg/day, demonstrating safety within these dosing parameters [PMID:39264732].

Complications

The study reported a low incidence of safety events among patients treated with oral ketamine, suggesting a favorable safety profile within this population [PMID:39264732].

References

1 Hetrick M, Casey E, Radcliff J, Uritsky T. Characterization of Oral Ketamine Use: A Retrospective Review. Journal of pain & palliative care pharmacotherapy 2025. link

1 papers cited of 3 indexed.

Original source

  1. [1]
    Characterization of Oral Ketamine Use: A Retrospective Review.Hetrick M, Casey E, Radcliff J, Uritsky T Journal of pain & palliative care pharmacotherapy (2025)

HemoChat

by SPINAI

Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

⚕ For clinical reference only. Not a substitute for professional judgment.

© 2026 HemoChat. All rights reserved.
Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG